311
Views
20
CrossRef citations to date
0
Altmetric
Original Article

Effect of selected antihypertensives, antidiabetics, statins and diuretics on adjunctive medical treatment of glaucoma: A population based study*

, , , , , & show all
Pages 1879-1888 | Accepted 12 May 2009, Published online: 17 Jun 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Rachel Williams & Alex Hui. (2022) Common systemic medications that every optometrist should know. Clinical and Experimental Optometry 105:2, pages 149-156.
Read now
Ehtesham Shamsher, Benjamin M. Davis, Timothy E. Yap, Li Guo & Maria Francesca Cordeiro. (2019) Neuroprotection in glaucoma: old concepts, new ideas. Expert Review of Ophthalmology 14:2, pages 101-113.
Read now
Ben Whigham, Eugene Z. Oddone, Sandra Woolson, Cynthia Coffman, R. Rand Allingham, Christine Shieh & Kelly W. Muir. (2018) The influence of oral statin medications on progression of glaucomatous visual field loss: A propensity score analysis. Ophthalmic Epidemiology 25:3, pages 207-214.
Read now
Jordana K Schmier, Edmund C Lau & David W Covert. (2010) Two-year treatment patterns and costs in glaucoma patients initiating treatment with prostaglandin analogs. Clinical Ophthalmology 4, pages 1137-1143.
Read now

Articles from other publishers (16)

Jihye Kim, Marianne T. Kennedy Neary, Hugues Aschard, Mathew M. Palakkamanil, Ron Do, Janey L. Wiggs, Anthony P. Khawaja, Louis R. Pasquale & Jae H. Kang. (2022) Statin Use in Relation to Intraocular Pressure, Glaucoma, and Ocular Coherence Tomography Parameters in the UK Biobank. Investigative Opthalmology & Visual Science 63:5, pages 31.
Crossref
Jessica Minjy Kang, Alessandro Adad Jammal & Felipe A Medeiros. (2022) Association between statin use and rates of structural and functional loss in glaucoma. British Journal of Ophthalmology, pages bjophthalmol-2021-320734.
Crossref
Yixiong Yuan, Ruilin Xiong, Yi Wu, Jason Ha, Wei Wang, Xiaotong Han & Mingguang He. (2022) Associations of statin use with the onset and progression of open-angle glaucoma: A systematic review and meta-analysis. eClinicalMedicine 46, pages 101364.
Crossref
Stephanie A. Pumphrey, Emily Zitek-Morrison, Stefano Pizzirani & Dawn M. Meola. (2021) Evaluation of matrix metalloproteinases and tissue inhibitors of metalloproteinases in aqueous humor of dogs with versus without naturally occurring primary angle-closure glaucoma. American Journal of Veterinary Research, pages 1-11.
Crossref
Nobuhiro Ooba, Rira Iwahashi, Akiko Nogami, Toshimitsu Nakayama, Atsushi Kanno, Naohiro Tochikura, Susumu Ootsuka & Noriyasu Fukuoka. (2020) Comparison between high and low potency statins in the incidence of open-angle glaucoma: A retrospective cohort study in Japanese working-age population. PLOS ONE 15:8, pages e0237617.
Crossref
Annie Wu, Anthony P. Khawaja, Louis R. Pasquale & Joshua D. Stein. (2019) A review of systemic medications that may modulate the risk of glaucoma. Eye 34:1, pages 12-28.
Crossref
Konstantinos Pappelis, Allison R. Loiselle, Stijn Visser & Nomdo M. Jansonius. (2019) Association of Systemic Medication Exposure With Glaucoma Progression and Glaucoma Suspect Conversion in the Groningen Longitudinal Glaucoma Study. Investigative Opthalmology & Visual Science 60:14, pages 4548.
Crossref
Kilhwan Shon & Kyung Rim Sung. (2019) Dyslipidemia, Dyslipidemia Treatment, and Open-angle Glaucoma in the Korean National Health and Nutrition Examination Survey. Journal of Glaucoma 28:6, pages 550-556.
Crossref
Kenneth G.-J. Ooi, Pauline Khoo, Veronika Vaclavik & Stephanie L. Watson. (2019) Statins in ophthalmology. Survey of Ophthalmology 64:3, pages 401-432.
Crossref
Tenley Bower, Deborah Anne Samek, Ahmed Mohammed, Ali Mohammed, Paul Kasner, David Camoriano & Oscar Kasner. (2018) Systemic medication usage in glaucoma patients. Canadian Journal of Ophthalmology 53:3, pages 242-245.
Crossref
Hsin-Yi Chen, Sheng-Yao Hsu, Yue-Cune Chang, Che-Chen Lin, Fung-Chang Sung, Wen-Chi Chen & Chia-Huang Kao. (2015) Association Between Statin Use and Open-angle Glaucoma in Hyperlipidemia Patients. Medicine 94:45, pages e2018.
Crossref
Di Zhao, Juhee Cho, Myung Hun Kim & Eliseo Guallar. (2014) The Association of Blood Pressure and Primary Open-Angle Glaucoma: A Meta-analysis. American Journal of Ophthalmology 158:3, pages 615-627.e9.
Crossref
O. Pokrovskaya, D. Wallace & C. O’Brien. (2014) The Emerging Role of Statins in Glaucoma Pathological Mechanisms and Therapeutics. Open Journal of Ophthalmology 04:04, pages 124-138.
Crossref
Joshua D. Stein, Paula Anne Newman-Casey, Nidhi Talwar, Bin Nan, Julia E. Richards & David C. Musch. (2012) The Relationship Between Statin Use and Open-Angle Glaucoma. Ophthalmology 119:10, pages 2074-2081.
Crossref
Michael W. Marcus, Rogier P. H. M. Müskens, Wishal D. Ramdas, Roger C. W. Wolfs, Paulus T. V. M. De Jong, Johannes R. Vingerling, Albert Hofman, Bruno H. Stricker & Nomdo M. Jansonius. (2012) Cholesterol-Lowering Drugs and Incident Open-Angle Glaucoma: A Population-Based Cohort Study. PLoS ONE 7:1, pages e29724.
Crossref
Michael Iskedjian, David W. Covert & John H. Walker. (2011) Persistence with Prostaglandin Agonist Use with and without Adjunctive Therapy for Glaucoma Patients. The Patient: Patient-Centered Outcomes Research 4:2, pages 133-141.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.